Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes AS    NZYM B   DK0060336014


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Novozymes B : BASF, Cargill and Novozymes target commercial bio-based acrylic acid process

share with twitter share with LinkedIn share with facebook
share via e-mail
08/17/2012 | 04:21am EST

Joint R&D cooperation to develop an industrial biotechnology-based production process for acrylic acid from renewable raw materials. Key raw material for the production of bio-based superabsorbents for baby diapers.

17. August 2012

Page Content

BASF, Cargill and Novozymes have signed an agreement to develop technologies to produce acrylic acid from renewable raw materials.

Presently, acrylic acid is produced by the oxidation of propylene derived from the refining of crude oil. BASF - The Chemical Company, Cargill and industrial biotechnology company Novozymes will develop bio-based technologies to produce acrylic acid from renewable feedstocks.

"The cooperation combines BASF's global market strength and innovation power with the excellent know-how and competencies of Novozymes and Cargill who are global leaders in their respective industry segments. Together we are uniquely positioned to more sustainably meet market and society needs", said Michael Heinz, Member of the Board of Executive Directors of BASF SE.

New milestone towards commercialization
Novozymes and Cargill have collaborated on renewable acrylic acid technology since 2008. Both companies have worked to develop microorganisms that can efficiently convert renewable feedstock into 3-hydroxypropionic acid (3-HP), which is one possible chemical precursor to acrylic acid. BASF has now joined the collaboration to develop the process for conversion of 3-HP into acrylic acid.

BASF is the world´s largest producer of acrylic acid and has substantial capabilities in its production and downstream processing. The company plans initially to use the bio-based acrylic acid to manufacture superabsorbent polymers.

The three companies bring complementary knowledge to the project. Novozymes, the world-leader in industrial enzymes, has years of experience with developing technologies for bio-based production of chemicals used in plastics, ingredients, etc.

"BASF and Cargill are global leaders in their industries and we are very excited to partner with them," says Novozymes CEO Steen Riisgaard. "By offering bio-based alternatives to fossil-based products we will take a big step towards a more sustainable economy."

"Cargill is pleased to bring its global expertise in sourcing renewable feedstocks and large-scale fermentation to this collaborative project", said Chris Mallett, Cargill Corporate Vice President of research and development. "The work with BASF and Novozymes underscores our commitment to developing innovative new technologies that help our customers meet their business objectives."

Acrylic acid is a high-volume chemical that feeds into a broad range of products. One of the main applications is in the manufacture of superabsorbent polymers that can soak up large amounts of liquid and are used mainly in baby diapers and other hygiene products. Acrylic acid is also used in adhesive raw materials and coatings. The annual global market volume of acrylic acid is around 4.5 million tons with a value of $11 billion* at the end of 2011. The market has been growing at a rate of 4 percent per year.

About BASF
BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success, social responsibility and environmental protection. Through science and innovation we enable our customers in almost all industries to meet the current and future needs of society. Our products and system solutions contribute to conserving resources, ensuring healthy food and nutrition and helping to improve the quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF posted sales of about €73.5 billion in 2011 and had more than 111,000 employees as of the end of the year. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.

About Cargill
Cargill is an international producer and marketer of food, agricultural, financial and industrial products and services. Founded in 1865, the privately held company employs 140,000 people in 65 countries. Cargill helps customers succeed through collaboration and innovation, and is committed to applying its global knowledge and experience to help meet economic, environmental and social challenges wherever it does business. For more information, visit Cargill.com and its news center.

*Based on ICIS pricing

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NOVOZYMES AS
11/18NOVOZYMES : Transactions under Novozymes' stock buyback program
11/17NOVOZYMES : Danish firm launching 'Livelong solution' in Bangladesh
11/05NOVOZYMES : Trading by management and close relations of management
11/04NOVOZYMES : Transactions under Novozymes' stock buyback program
10/30NOVOZYMES : Ester Baiget appointed new CEO of Novozymes
10/23NOVOZYMES : Interim report for the first nine months of 2019
10/23NOVOZYMES AS : Slide show Q3 results
10/21NOVOZYMES : Transactions under Novozymes' stock buyback program
10/15NOVOZYMES : Change to the Executive Leadership Team
More news
Financials (DKK)
Sales 2019 14 421 M
EBIT 2019 3 928 M
Net income 2019 3 085 M
Debt 2019 3 598 M
Yield 2019 1,60%
P/E ratio 2019 30,7x
P/E ratio 2020 29,6x
EV / Sales2019 6,68x
EV / Sales2020 6,45x
Capitalization 92 793 M
Duration : Period :
Novozymes AS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVOZYMES AS
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 19
Average target price 299,33  DKK
Last Close Price 329,90  DKK
Spread / Highest target 18,2%
Spread / Average Target -9,27%
Spread / Lowest Target -27,3%
EPS Revisions
Peder Holk Nielsen President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Thomas Videbaek COO, Executive VP-Research, Innovation & Supply
Lars Green Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang VP-Franklinton Biofuel, Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES AS13.44%13 794
ECOLAB INC.25.59%53 340
HENKEL AG & CO. KGAA-1.64%42 874
GIVAUDAN28.08%27 217
SIKA AG39.77%22 765